A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
for Colo-rectal Cancer
Drug: Cemiplimab
Sites in Pinehurst +12 more locations
Sponsor: NSABP Foundation Inc
Sex: All·Age: 18+
Code: NCT07058012·Phase 2·Recruiting·Listed Jul 2025